Cargando…

Editorial: Inhibiting PARP as a Strategic Target in Cancer

Detalles Bibliográficos
Autores principales: Zorn, Kristin K., Annunziata, Christina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831976/
https://www.ncbi.nlm.nih.gov/pubmed/27148483
http://dx.doi.org/10.3389/fonc.2016.00091
_version_ 1782427172185571328
author Zorn, Kristin K.
Annunziata, Christina M.
author_facet Zorn, Kristin K.
Annunziata, Christina M.
author_sort Zorn, Kristin K.
collection PubMed
description
format Online
Article
Text
id pubmed-4831976
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-48319762016-05-04 Editorial: Inhibiting PARP as a Strategic Target in Cancer Zorn, Kristin K. Annunziata, Christina M. Front Oncol Oncology Frontiers Media S.A. 2016-04-15 /pmc/articles/PMC4831976/ /pubmed/27148483 http://dx.doi.org/10.3389/fonc.2016.00091 Text en Copyright © 2016 Zorn and Annunziata. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zorn, Kristin K.
Annunziata, Christina M.
Editorial: Inhibiting PARP as a Strategic Target in Cancer
title Editorial: Inhibiting PARP as a Strategic Target in Cancer
title_full Editorial: Inhibiting PARP as a Strategic Target in Cancer
title_fullStr Editorial: Inhibiting PARP as a Strategic Target in Cancer
title_full_unstemmed Editorial: Inhibiting PARP as a Strategic Target in Cancer
title_short Editorial: Inhibiting PARP as a Strategic Target in Cancer
title_sort editorial: inhibiting parp as a strategic target in cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831976/
https://www.ncbi.nlm.nih.gov/pubmed/27148483
http://dx.doi.org/10.3389/fonc.2016.00091
work_keys_str_mv AT zornkristink editorialinhibitingparpasastrategictargetincancer
AT annunziatachristinam editorialinhibitingparpasastrategictargetincancer